No abstract available
Publication types
-
Clinical Trial
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Angiogenesis Inhibitors / administration & dosage
-
Antibodies, Monoclonal, Humanized / administration & dosage
-
Antineoplastic Agents, Alkylating / administration & dosage
-
Antineoplastic Agents, Hormonal / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bevacizumab
-
Dacarbazine / administration & dosage
-
Dacarbazine / analogs & derivatives
-
Female
-
Humans
-
Male
-
Middle Aged
-
Neuroendocrine Tumors / drug therapy*
-
Octreotide / administration & dosage
-
Temozolomide
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Alkylating
-
Antineoplastic Agents, Hormonal
-
Bevacizumab
-
Dacarbazine
-
Octreotide
-
Temozolomide